DEKSMEDETOMIDIN PHARMIDEA 100 µg/1 mL koncentrat za rastvor za infuziju Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

deksmedetomidin pharmidea 100 µg/1 ml koncentrat za rastvor za infuziju

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - deksmedetomidin - koncentrat za rastvor za infuziju - 100 µg/1 ml - 1 ml koncentrata za rastvor za infuziju sadrži 100 mikrograma deksmedetomidina (u obliku deksmedetomidinhidrohlorida)

Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) Europska Unija - hrvatski - EMA (European Medicines Agency)

lenalidomide krka (previously lenalidomide krka d.d. novo mesto)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imunosupresivi - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 i 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) indiciran za liječenje odraslih bolesnika s ranije нелеченной multiplog mijeloma koji se ne oslanja transplantacije. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 i 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Zonisamid Makpharm 100 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

zonisamid makpharm 100 mg tvrde kapsule

makpharm d.o.o., folnegovićeva 1/a, zagreb, hrvatska - zonisamid - kapsula, tvrda - 100 mg - urbroj: svaka tvrda kapsula sadrži 100 mg zonisamida

Zonisamid Makpharm 25 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

zonisamid makpharm 25 mg tvrde kapsule

makpharm d.o.o., folnegovićeva 1/a, zagreb, hrvatska - zonisamid - kapsula, tvrda - 25 mg - urbroj: svaka tvrda kapsula sadrži 25 mg zonisamida

Zonisamid Makpharm 50 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

zonisamid makpharm 50 mg tvrde kapsule

makpharm d.o.o., folnegovićeva 1/a, zagreb, hrvatska - zonisamid - kapsula, tvrda - 50 mg - urbroj: svaka tvrda kapsula sadrži 50 mg zonisamida

Zomig Rapimelt 2,5 mg raspadljive tablete za usta Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

zomig rapimelt 2,5 mg raspadljive tablete za usta

astrazeneca d.o.o., radnička cesta 80, zagreb, hrvatska - zolmitriptan - raspadljiva tableta za usta - 2,5 mg - urbroj: jedna raspadljiva tableta za usta sadrži 2,5 mg zolmitriptana

Olimestra 10 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

olimestra 10 mg filmom obložene tablete

krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - olmesartanmedoksomil - filmom obložena tableta - 10 mg - urbroj: svaka filmom obložena tableta sadrži 10 mg olmesartanmedoksomila